ArticleInternational journal of immunopathology and pharmacology

A monoclonal antibody against basic fibroblast growth factor attenuates cisplatin resistance in lung cancer by suppressing the epithelial-mesenchymal transition.

Penghui Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.